MedPath

Prevention of late presentation of an HIV infectio

Completed
Conditions
HIV prevalentieHIV prevalence
Registration Number
NL-OMON22242
Lead Sponsor
Prof.dr. A. Verbon, Dr. TEMS de Vries-Sluijs, Dhr. G.P.M. Luiken; Erasmus MC, RotterdamProf.dr. J.M. Prins; AMC, AmterdamDr. J.G. den Hollander; Maasstad zh, Rotterdam
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
4500
Inclusion Criteria

All patients, >=18 years of age will be included when presenting at the Emergency Department and blood sample will be taken for diagnostic purposes

- Informed consent

Exclusion Criteria

- < 18 years

- No informed consent

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primairy endpoint is the prevalence of HIV infection in the population presenting at the Emergency Department
Secondary Outcome Measures
NameTimeMethod
Secundairy endpoint is the HIV prevalence in different high-risk groups
© Copyright 2025. All Rights Reserved by MedPath